Compare · OMCL vs WORX
OMCL vs WORX
Side-by-side comparison of Omnicell Inc. (OMCL) and SCWorx Corp. (WORX): market cap, price performance, sector, and recent activity on the wire.
Summary
- OMCL operates in Technology, while WORX operates in Consumer Discretionary - the two are in different parts of the market.
- OMCL is the larger of the two at $1.61B, about 944.4x WORX ($1.7M).
- WORX has been more active in the news (5 items in the past 4 weeks vs 3 for OMCL).
- OMCL has more recent analyst coverage (24 ratings vs 0 for WORX).
- Company
- Omnicell Inc.
- SCWorx Corp.
- Price
- -
- -
- Market cap
- $1.61B
- $1.7M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Manufacturing
- Services-Misc. Amusement & Recreation
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- 2016
- News (4w)
- 3
- 5
- Recent ratings
- 24
- 0
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
SCWorx Corp.
SCWorx Corp. provides software solutions for the management of health care providers' foundational business applications in the United States. The company provides services related to repair, normalization, and interoperability of information, as well as big data analytics model that provides web portal for display, and reporting and analysis of the information contained within the data warehouse. It also offers various software solutions and services, such as virtualized item master file repair, expansion, and automation; electronic medical record management, a module that integrates the advanced data attributes created in the item master to the electronic medical records; charge description master management(CDM), a module, which assists healthcare providers by integrating the CDM data into the workflow of the hospitals purchasing systems; contract management, a module that assists healthcare providers to establish a contract management system and to provide care to patients; request for proposal automation solution; rebate management; ScanWorx, a mobile perioperative closed loop scanning solution; and data integration and warehousing, as well as solutions for integration of acquired businesses, which enable deployment of a virtual item master files. The company sells its solutions and services to hospitals and health systems through its distribution and reseller partnerships. In addition, it offers CageTix, a ticketing platform for mixed martial arts industry. Further, the company focuses on selling rapid test kits for COVID-19; and personal protective equipment. SCWorx Corp. is based in New York, New York.
Latest OMCL
- SEC Form 10-Q filed by Omnicell Inc.
- SEC Form 8-K filed by Omnicell Inc.
- Omnicell Announces Third Quarter 2026 Financial Results
- Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
- TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
- Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
- EVP&CHIEF LEGAL/ADMIN OFFICER Manley Corey J covered exercise/tax liability with 4,025 shares, decreasing direct ownership by 4% to 108,985 units (SEC Form 4)
- VP, Chief Accounting Officer Nutt Brian H. covered exercise/tax liability with 937 shares, decreasing direct ownership by 4% to 22,266 units (SEC Form 4)
- President & COO Njoku Nnamdi covered exercise/tax liability with 3,670 shares and sold $113,609 worth of shares (3,083 units at $36.85) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 161,224 units (SEC Form 4)
- CHAIRMAN, CEO Lipps Randall A covered exercise/tax liability with 12,350 shares, decreasing direct ownership by 2% to 511,096 units (SEC Form 4)
Latest WORX
- SEC Form SCHEDULE 13G filed by SCWorx Corp.
- SEC Form 424B3 filed by SCWorx Corp.
- SEC Form EFFECT filed by SCWorx Corp.
- Amendment: SEC Form S-3/A filed by SCWorx Corp.
- SCWorx Announces New Agreement with Healthcare System
- SEC Form S-3 filed by SCWorx Corp.
- SCWorx Announces Resumption of Nasdaq Trading and Highlights Improved Operating Performance and Growth Strategy
- SCWorx Announces Nasdaq Trading to Resume October 7, 2026
- SCWorx Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- SCWorx Corp. Announces Nasdaq Hearings Panel Grants Request for Reconsideration and Approves Continued Listing on The Nasdaq Capital Market